CN104688943A - Preparation for treating suppurative osteomyelitis in pus formation stage - Google Patents
Preparation for treating suppurative osteomyelitis in pus formation stage Download PDFInfo
- Publication number
- CN104688943A CN104688943A CN201310644629.5A CN201310644629A CN104688943A CN 104688943 A CN104688943 A CN 104688943A CN 201310644629 A CN201310644629 A CN 201310644629A CN 104688943 A CN104688943 A CN 104688943A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- formation stage
- pus
- pus formation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a preparation for treating suppurative osteomyelitis in the pus formation stage, and belongs to the technical field of traditional Chinese medicinal preparations. The preparation is mainly prepared by using unprepared rehmannia root, honeysuckle flower, Rhizoma Coptidis, Poria cocos, Herba Violae, dahurian angelica root, pangolin and other three raw materials, and is processed through pharmacy devices to prepare a capsule, a tablet, a particle, an oral liquid and other different dosage forms for later use. The preparation has heat clearing, dampness draining, ying harmonizing and toxin draining functions, has a good treatment effect on suppurative osteomyelitis in the pus formation stage, is safe and has no toxic side effects.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicine preparation.
Background technology
Pyogenic infection of the bone is apt to occur in child, and general point of early stage, pus becomes phase and Collapse later stage three phases, and its treatment means is not quite similar.Pus becomes the phase to be after disease about about 1-3 months, and fever of the body is persistent, and Se Hong Pan swells, and bone is obviously swollen.If now timely and effective treatment can be obtained, patient's slight illness can be alleviated and accelerate recovery from illness.Modern medicine generally uses antibiotic to the treatment that this demonstrate,proves.But in recent years due to abuse of antibiotics, make pathogenic bacteria create Drug resistance, add treatment difficulty and toxic and side effects.
Summary of the invention
The object of the invention is to overcome the deficiencies in the prior art, provide a kind of and treat the preparation that pus becomes phase pyogenic infection of the bone.It has clearing away heat-damp and promoting diuresis, and the function of battalion's poison holding, and treatment pus becomes phase pyogenic infection of the bone effective.Determined curative effect can be reached, the object of safe without toxic side effect.
The technical solution adopted for the present invention to solve the technical problems is: be made up of Radix Rehmanniae, Radix Scutellariae, Flos Lonicerae, Rhizoma Coptidis, Poria, Herba Violae, the Radix Angelicae Dahuricae, Fructus Forsythiae, Spina Gleditsiae, Squama Manis 10 kinds of crude drug.
About ingredient major function and preparation in invention formulation.
Radix Rehmanniae in the present invention, nature and flavor are sweet, cold.Containing mannitol, glucose, alkaloid, fatty acid, rehmanin etc.Nourishing YIN to lower pathogenic fire, hemopoietic removing heat from blood.Cure mainly epidemic febrile disease impairment of YIN, large hot excessive thirst, macule, quenches one's thirst, bleeding due to blood-heat.
Radix Scutellariae in the present invention, nature and flavor are bitter, cold.Containing baicalin, wogonoside, glucuronic acid, enzyme etc.Clearing away damp-heat, purte the white, antiabortive removing toxic substances.
Flos Lonicerae in the present invention, nature and flavor are sweet, cold.Containing Flos Lonicerae glycoside, inositol, Saponin etc.Heat-clearing and toxic substances removing, cures mainly epidemic febrile disease heating, carbuncle, scabies, malignant boil, toxic swelling, toxic-heat and blood stasis, pneumonia, laryngopharynx swelling and pain, anemopyretic cold etc.
Rhizoma Coptidis in the present invention, nature and flavor are bitter, cold.Containing 13-methyl-.psi.-coptisine., palmatine etc.Pathogenic fire purging dampness, relieving restlessness is detoxified.Curing mainly Hot contains vexed, and feeling of fullness, quenches one's thirst, and Hot dysentery is suffered from abdominal pain, tenesmus, conjunctival congestion and swelling pain, carbuncle sore tumefacting virus, aphtha.
Poria in the present invention, nature and flavor are sweet, light, flat.Containing pachymic acid, ergosterol, choline, lecithin etc.Eliminating dampness and diuresis, tranquilizing mind, strengthening the spleen stomach.Cure mainly spleen-asthenia with excessive damp, edema distension, phlegm retention cough with dyspnea, dirty having loose bowels of vomitting, dysuria.
Herba Violae in the present invention, nature and flavor are bitter, cold.Containing glycoside, flavonoid, wax etc.Heat-clearing and toxic substances removing.Cure mainly ulcer sores, scrofula malignant boil.
The Radix Angelicae Dahuricae in the present invention, nature and flavor are pungent, temperature.Containing Radix Angelicae Dahuricae element, Radix Angelicae Dahuricae ether, phellopterin.Expelling pathogenic wind and eliminating dampness, promoting blood circulation and stopping pain, granulation promoting evacuation of pus.Cure mainly flu headache, supraorbital pain, toothache, nasal sinusitis, hemorrhoidal hamorrhage anal fistula, leucorrhea with red and white discharge, carbuncle epidemic disease poison, skin pruritus.
Fructus Forsythiae in the present invention, nature and flavor are bitter, cold.Containing Saponin, phenol glycoside, alkaloid, vitamin etc.Heat-clearing and toxic substances removing, mass dissipating and swelling eliminating, evacuation of pus.Cure mainly calentura from the beginning of, skin infection, scrofula, erysipelas, pyretic stranguria, macule, dysuria.
Spina Gleditsiae in the present invention, nature and flavor are pungent, temperature.Containing flavonoid glycoside, aminoacid, phenols.Dissatisfied wind, parasite killing, poison holding, carbuncle of bursting.Cure mainly carbuncle, sore, malignant boil, swell and ache non-Collapse, tinea skin ulcer, placenta retention.
Squama Manis in the present invention, nature and flavor are salty, are slightly cold.Containing protein, inorganic salt etc.Promoting blood circulation to remove obstruction in the collateral, detumescence and apocenosis, lower milk.Cure mainly carbuncle sore tumefacting virus, acute mastitis, galactostasis, rheumatic arthritis etc.
The etiology and pathogenesis of pyogenic infection of the bone is that remaining heresy is clear, damp and hot interior Sheng, in poison gos deep into, or extrinsic damage, it is evil that local bone damage experiences again poison, congestion heat-transformation, so that meridians block, and sluggish muscles and bones is for suffering from.The present invention has clearing away heat and eliminating dampness, clots absorbing dredging collateral, and the function of battalion's poison holding, and it is effective to treat into the pus phase.The invention has the beneficial effects as follows through clinical practice prove treat into pus phase pyogenic infection of the bone determined curative effect, safe without toxic side effect.
Detailed description of the invention
1. formula and part by weight: Radix Rehmanniae 18 parts, Radix Scutellariae 15 parts, Flos Lonicerae 20 parts, Rhizoma Coptidis 10 parts, 12 parts, Poria, Herba Violae 35 parts, the Radix Angelicae Dahuricae 15 parts, Fructus Forsythiae 16 parts, Spina Gleditsiae 12 parts, Squama Manis 12 parts.
2. manufacture method: weighed in proportion by above-mentioned raw materials medicine and assort, it is qualified to concoct with pharmaceutical equipment apparatus, and purifying, it is for subsequent use to make the different dosage forms such as capsule, tablet, pill, granule, oral liquid after concentrating.
Claims (1)
1. treat into a preparation for pus phase pyogenic infection of the bone, it is characterized in that formula and part by weight are Radix Rehmanniae 18 parts, Radix Scutellariae 15 parts, Flos Lonicerae 20 parts, Rhizoma Coptidis 10 parts, 12 parts, Poria, Herba Violae 35 parts, the Radix Angelicae Dahuricae 15 parts, Fructus Forsythiae 16 parts, Spina Gleditsiae 12 parts, Squama Manis 12 parts; Weighed in proportion by above-mentioned raw materials medicine and assort, it is qualified to concoct with pharmaceutical equipment apparatus, and purifying, it is for subsequent use to make the different dosage forms such as capsule, tablet, pill, granule, oral liquid after concentrating.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310644629.5A CN104688943A (en) | 2013-12-05 | 2013-12-05 | Preparation for treating suppurative osteomyelitis in pus formation stage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310644629.5A CN104688943A (en) | 2013-12-05 | 2013-12-05 | Preparation for treating suppurative osteomyelitis in pus formation stage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104688943A true CN104688943A (en) | 2015-06-10 |
Family
ID=53336767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310644629.5A Pending CN104688943A (en) | 2013-12-05 | 2013-12-05 | Preparation for treating suppurative osteomyelitis in pus formation stage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104688943A (en) |
-
2013
- 2013-12-05 CN CN201310644629.5A patent/CN104688943A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104027469A (en) | Drug for treating neck abscess and preparing method thereof | |
| CN104606385A (en) | Traditional Chinese medicine preparation for treating paronychia | |
| CN104644891A (en) | Felon treating traditional Chinese medicine preparation | |
| CN101129627A (en) | Traditional Chinese medicine formulated product for treating post partum toxin fever | |
| CN104644889A (en) | Finger pulp pustule treating external application paste | |
| CN104623112A (en) | Plaster for treating snake-head furuncle | |
| CN105213831A (en) | A kind of Chinese medicine composition for the treatment of epidemic hemorrhagic fever | |
| CN104688943A (en) | Preparation for treating suppurative osteomyelitis in pus formation stage | |
| CN104688946A (en) | Medicine for treating early suppurative osteomyelitis | |
| CN104606389A (en) | Medicament for treating face furunculosis | |
| CN104623111A (en) | Drug for treating palmar furuncle | |
| CN104644892A (en) | Cutaneous anthrax treating drug | |
| CN104623113A (en) | Drug for treating snake belly furuncle | |
| CN104587021A (en) | External application preparation for treatment of umbilical carbuncle | |
| CN104623115A (en) | Traditional Chinese medicine preparation for treating acute lymphangitis | |
| CN104688905A (en) | Traditional Chinese medicinal preparation for treating suppurative osteomyelitis | |
| CN105267326A (en) | Drug for treating pus forming stage suckling-period acute mastitis | |
| CN104688945A (en) | Plaster for the treatment of suppurative osteomyelitis in pus formation period | |
| CN104606401A (en) | Medicament for treating umbilical abscess | |
| CN104606330A (en) | Traditional Chinese medicine preparation for treating gluteal abscess | |
| CN104606387A (en) | Poison drawing out ointment | |
| CN105012447A (en) | Medicine for treating qi-blood deficiency vulval swelling | |
| CN104688944A (en) | External application plaster for treating early stage suppurative osteomyelitis | |
| CN104606329A (en) | Ointment for treating gluteal abscess | |
| CN103784755A (en) | Traditional Chinese medicinal decoction for treating scarlet fever |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150610 |